Skip to content

Lentivirus preparation

Version 1.4LK, DD, JCHFirst posted Last updated

Materials
Reagent / consumable Supplier Cat. no.
TransIT-LT1 Transfection Reagent Mirus Bio MIR 2300
Opti-MEM I Reduced-Serum Medium Gibco 31985070
Syringe filter, 0.45 µm (yellow) Millipore SLHV033RS
psPAX2 (EX02), packaging plasmid Addgene 12260
pMD2.G (EX01), envelope plasmid Addgene 12259
4× Lentivirus Concentrator Solution in-house recipe
  • HEK293T standard medium: DMEM, 10 % FBS, 1 % P/S
  • HEK293T virus-production medium: DMEM, 20 % FBS, 1 % P/S
Timeline

Transfection can be performed 12–24 h after plating, which gives two workable schedules. From the medium change onwards both are identical.

Step Option A (12 h) Option B (24 h)
Plating Day 1, 8AM Day 1, 8AM
Transfection Day 1, 8 PM Day 2, 8AM
Medium change Day 2, 8 AM Day 2, 8PM
Collect supernatant 1 (SN1) Day 3 Day 3
Collect supernatant 2 (SN2) Day 4 Day 4

In a fast-paced experiment, you could use your first supernatant (SN1) to directly transduce cells. With option A this means going from HEK293T plating to transduction in 48h.

HEK293T cells are generally plated at 2×105/ml.
The exception are 10cm dishes where we reduce the culture volume from the usual 15ml to 10ml to reduce the amount of transfection reagent, bringing the concentration to 3×105/ml.

96-well (0.35 cm²) 48-well (0.9 cm²) 24-well (1.9 cm²) 12-well (3.8 cm²) 6-well (9.6 cm²) 10 cm dish (59 cm²)
Volume 0.1 ml 0.3 ml 0.6 ml 1.2 ml 2.5 ml 10 ml
Cell number 0.2×105 0.6×105 1.2×105 2.4×105 5×105 3×106
Cell suspension 2×105/ml 2×105/ml 2×105/ml 2×105/ml 2×105/ml 3×105/ml

Transfection (day 1 evening or day 2 morning)

Section titled “Transfection (day 1 evening or day 2 morning)”

Confluency should be around 80 % at transfection. Use the EVOS M3000 to objectively measure confluency and document this in your lab notebook.

We use TransIT-LT1 as a transfection reagent but adapt the protocol in that we usually prepare separate DNA and TransIT dilutions which are then mixed (as in the Lipofectamine 2000 protocol):

  1. Dilute the DNA in Optimem (half of the final volume, e.g. 125 µl for 6-well).
  2. Dilute TransIT in Optimem (half of the final volume, e.g. 125 µl for 6-well) and incubate for 5 min (max. 30 min).
  3. Combine both dilutions, mix gently and incubate at room temperature for 15–30 min.
  4. Apply the TransIT:DNA complexes to the cells drop-wise, to different areas of the well, and distribute by rocking the plate gently.

The DNA to TransIT-LT1 ratio is 1 µg : 3 µl. The standard pMD2.G : psPAX2 : transfer vector ratio is 1:3:4. The 10 cm dish amounts here deviate from the TransIT-LT1 protocol, because of the reduced culture volume we use at this step (10 ml instead of 15 ml). The reasoning behind these choices, and when to use something else, is in Protocol notes and open questions.

96-well (0.35 cm²) 48-well (0.9 cm²) 24-well (1.9 cm²) 12-well (3.8 cm²) 6-well (9.6 cm²) 10 cm dish (59 cm²)
pMD2.G (EX01) 12 ng 36 ng 70 ng 140 ng 300 ng 1.25 µg
psPAX2 (EX02) 36 ng 108 ng 210 ng 420 ng 900 ng 3.75 µg
transfer plasmid 48 ng 144 ng 280 ng 560 ng 1200 ng 5 µg
total DNA 96 ng 288 ng 560 ng 1120 ng 2.4 µg 10 µg
TransIT-LT1 0.3 µl 0.9 µl 1.8 µl 3.6 µl 7.2 µl 30 µl
Optimem (total) 9 µl 27 µl 54 µl 108 µl 250 µl 1.5 ml

Mastermixes for steps 1 and 2 are usually set up as follows (6-well example):

DNA mastermix 1-fold 6-fold
psPAX2 900 ng 5400 ng
pMD2.G 300 ng 1800 ng
transfer plasmid (pLKO) 1200 ng added to each condition individually
Optimem 125 µl 750 µl

The DNA:Optimem mastermix for packaging and envelope plasmids is distributed to individual tubes (6-well: 125 µl per condition), and the indicated amount of transfer vector is added.

TransIT mastermix 1-fold 6-fold
TransIT-LT1 7.2 µl 43.2 µl
Optimem 125 µl 750 µl
  1. After ~5 min incubation (max. 30 min) of the TransIT:Optimem mastermix, add the indicated amount (6-well: 125 µl) to each DNA:Optimem mix and incubate at room temperature for 15–30 min.
  2. Add the TransIT:DNA:Optimem mix to the cells, distributing it as evenly as possible.

12–18 h after transfection, change the medium to virus-production medium (DMEM, 20 % FBS, 1 % P/S; volumes below).

96-well 48-well 24-well 12-well 6-well 10 cm dish
Volume per supernatant change 125 µl 300 µl 750 µl 1.5 ml 3 ml 15 ml
Final / total supernatant volume 250 µl 600 µl 1.5 ml 3 ml 6 ml 30 ml
  1. Transfer the supernatant (SN1) to a collection tube (15 ml or 50 ml) and store at 4 °C.
  2. Replace with fresh virus-production medium.
  1. Transfer the supernatant (SN2) to the collection tube, pooling it with SN1.

At this point the lentivirus supernatant can be used for a fresh infection, or concentrated for storage and later use. Fresh infection is the most efficient and fastest way to transduce cells. Either way, the HEK293T cells are first removed from the supernatant:

  • Clearing by centrifugation: spin the supernatant at 800 × g for 10 min (MD Anderson) or up to 3000 × g for 15 min (Retro-Concentin) at room temperature.
  • Clearing by filtration: pass the supernatant through a yellow 0.45 µm Millipore filter.

Carefully transfer the cleared supernatant into a new tube.

Follows the homemade lentivirus concentrator protocol of the MD Anderson Functional Genomics Core. The 4× stock is made in-house: see 4× Lentivirus Concentrator Solution.

  1. Add 1 volume of 4× concentrator to 3 volumes of cleared supernatant (final: 10 % PEG-8000, 0.3 M NaCl).
  2. Mix well by shaking for 60 s, then incubate at 4 °C for at least 4 h, better overnight.
  3. Spin down at 1600 × g for 60 min at 4 °C.
  4. Carefully remove the supernatant without disturbing the pellet.
  5. Thoroughly resuspend the viral pellet in PBS or the desired medium (without serum and antibiotics) at 1/10–1/20 of the original volume, by gently pipetting up and down.
  6. Aliquot and store at −80 °C until use.

Numerous protocols are available for lentivirus production. Most follow the same basic workflow but vary in their choice of transfection reagent and in the ratios of the plasmids used.
Our protocol mainly follows the RNAi Consortium (TRC) / Broad Institute protocol for lentivirus production. The Broad protocol is very detailed and, judging by its version notes, has been continuously optimized. It is available at the Broad GPP portal (TRC shRNA sgRNA ORF Low Throughput Viral Production, 2015-06).

The ratio of envelope to packaging to transfer plasmid ranges widely in published protocols, from 1 : 1.8 : 2.8 to 1 : 10 : 10.
To our knowledge, there is no experimentally established optimum.

Broad (6-well) Broad (10 cm) Trono lab (15 cm) Melnick lab (10 cm) Addgene (6 cm)
envelope (pMD2.G) 50 ng 0.9 µg 7.9 µg 1 µg 250 ng
packaging (psPAX2) 500 ng 9 µg 14.6 µg 3 µg 750 ng
transfer (pLKO) 500 ng 9 µg 22.5 µg 4 µg 1000 ng
ratio 1 : 10 : 10 1 : 10 : 10 1 : 1.8 : 2.8 1 : 3 : 4 1 : 3 : 4
Transfection reagent 3 µl (TransIT) 54 µl (TransIT) CaPO4 24 µl (FuGENE) 6 µl (FuGENE)
DNA : reagent 1 µg : 3 µl 1 µg : 2.7 µl n/a 1 µg : 3 µl 1 µg : 3 µl

The Trono lab protocol is written for 15 cm dishes and gives its amounts as one mix for five plates (39.5 / 73 / 112.5 µg); the column above is that mix divided by five. Their packaging plasmid is pCMVR8.74 rather than psPAX2.

Transfection reagent
Commonly used transfection reagents include Lipofectamine 2000, FuGENE and TransIT-LT1. We have used all of them and although we have not done a direct head-to-head comparison, they seem to be interchangeable. We use TransIT-LT1 mainly for economic reasons.

Ratios

  • We use a 1 : 3 : 4 ratio for envelope (pMD2.G) to packaging (psPAX2) to transfer plasmid. This follows the Melnick lab protocol and the Addgene protocol for pLKO.1 (#10878).
  • For larger transfer plasmids (e.g. Cas9), a ratio of 1 : 3 : 6 may be used. However, we have not systematically tested these ratios.
  • We use TransIT-LT1 at 1 µg DNA : 3 µl reagent. This is the manufacturer’s recommended starting ratio.

When not to use TransIT-LT1
TransIT-LT1 is expensive and the cost scales with the dish. At 10 cm and above, reserve it for cargo that is large or hard to package — Cas constructs and CRISPR gRNA libraries — where transfection efficiency has to be maximized and a failed prep costs more than the reagent. For routine large-scale preps, use PEI or calcium-phosphate transfection instead: both cost a fraction as much and work well with ordinary inserts. Large transfer vectors package less efficiently in general, which is also why the 1 : 3 : 6 ratio exists as an option for them (below).

10 cm dish protocols
The amounts of DNA and transfection reagent for a 10 cm dish are not scaled up proportionally from the 6-well protocol, but reduced relative to the TransIT-LT1 manufacturer’s protocol. The reduction follows the Melnick lab protocol and is probably feasible because we use a smaller culture volume at this step (10 ml rather than 15 ml).

  • Low intensity I (1:3:4) is our standard and is the column in the main transfection table: 10 µg total DNA and 30 µl TransIT-LT1.
  • For large transfer vectors, intensifying the transfection and/or changing the ratios can help.
  • High intensity (45 µl TransIT) corresponds to the TransIT manufacturer’s protocol.
  • Use a 1:3:6 ratio for large transfer vectors (e.g. Cas9 constructs).
low intensity I (1:3:4) low intensity II (1:3:6) moderate intensity (1:3:4) high intensity (1:3:4) high intensity (1:3:6)
pMD2.G (EX01) 1.25 µg 1 µg 1.5 µg 1.9 µg 1.5 µg
psPAX2 (EX02) 3.75 µg 3 µg 4.5 µg 5.7 µg 4.5 µg
transfer plasmid 5 µg 6 µg 6 µg 7.6 µg 9 µg
total DNA 10 µg 10 µg 12 µg ~15 µg 15 µg
TransIT-LT1 30 µl 30 µl 36 µl 45 µl 45 µl
Optimem (total) 1.5 ml 1.5 ml 1.5 ml 1.5 ml 1.5 ml
  • Virus-production medium: the Broad protocol suggests adding BSA instead of FBS to enhance virus production. This would be highly economical but we have not tested this ourselves.
  • Ratio of envelope to packaging to transfer plasmid: published protocols vary widely and we have not yet tested this systematically.
  • Constant rocking during the concentrator incubation does not appear to be necessary (see Virus concentration), but this has not been tested side by side.

Adapted from the Melnick lab protocol Lentivirus preparation (v1.1–v1.3).

  1. Broad Institute, Genetic Perturbation Platform. TRC shRNA sgRNA ORF Low Throughput Viral Production (2015-06). GPP protocols, accessed 2026-11-15.
  2. MD Anderson Cancer Center, Functional Genomics Core. Homemade lentivirus concentrator protocol and virus concentration protocol. Functional Genomics Core resources, accessed 2026-11-15.
  3. Mirus Bio. TransIT-LT1 Transfection Reagent protocol (ML001; MIR 2300, 2304, 2305, 2306). PDF, accessed 2026-11-15.
  4. Addgene. pLKO.1 – TRC Cloning Vector (Addgene plasmid #10878; protocol v1.0, December 2006), section E “Producing lentiviral particles”. addgene.org/protocols/plko, accessed 2026-11-15.
  5. Thermo Fisher Scientific. Lipofectamine 2000 Reagent protocol. PDF, accessed 2026-11-15.
  6. Trono lab, EPFL. Lentivirus production protocol. PDF, accessed 2026-11-15.
  7. System Biosciences. Retro-Concentin Retroviral Concentration Reagent user manual. PDF, accessed 2026-11-15.
Version history
Version Date Authors Changes
1.0 JCH First version.
1.1 JCH Added different intensities and ratios to the 10 cm transfection protocol.
1.2 JCH Short version.
1.3 13 Apr 2025 LK, DD Switched from PEG-it to the homemade lentivirus concentrator.
1.4 15 Nov 2026 JCH Online version: biosafety notice, timeline, materials with catalog numbers, 10 cm standard set to 10 µg DNA / 30 µl TransIT.